Emerging Psychedelic Therapies


Here's why psychedelics might be a valuable addition to mental health treatment.

Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.

Alexander Somjen is the CEO and Director of Origin Therapeutics.

Related Videos
nicotine use
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
© 2024 MJH Life Sciences

All rights reserved.